Extended Data Fig. 4: Maps showing how the impact malaria mitigation strategies are predicted to vary across sub-Saharan Africa.
From: The potential public health consequences of COVID-19 on malaria in Africa
a, Expansion of existing seasonal malaria chemoprevention (SMC) in regions where it occurred in the Sahel where it was conducted in 2019. Colours denote additional lives saved by expanding the age of those eligible from under 5 years to under 15 years. b, The predicted impact of mass drug administration (MDA) using a drug with a prophylactic profile of amodiaquine plus sulfadoxine-pyrimethamine for regions where SMC is not currently conducted. Both figures show scenarios where existing LLIN campaigns were maintained but routine treatment of clinical cases paused during the mitigated COVID-19 scenario.
